|
⚲
|
| Keyboard |
| Goodwin Bradford S
✚
|
|
|---|---|
| CIK # | 0001293633 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001293633] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Goodwin Bradford S | |
| Rigel Pharmaceuticals Inc | |
| NeurogesX Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2021-05-19 | Grant | 30,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Common Stock
|
2021-05-19 | Grant | 25,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2020-05-15 | Grant | 55,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2019-05-23 | Grant | 55,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2018-05-17 | Grant | 40,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2017-05-12 | Grant | 40,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2016-05-11 | Grant | 40,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2015-05-13 | Grant | 40,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2014-05-21 | Grant | 30,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2013-05-15 | Grant | 15,000 | $0.00 | |
|
NeurogesX Inc NGSX
Right to purchase Non-qualified Stock Option · derivative
|
2012-06-07 | Grant | 10,000 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
|
2012-05-23 | Grant | 15,000 | $0.00 | |
|
NeurogesX Inc NGSX
Right to purchase Non-qualified Stock Option · derivative
|
2012-02-07 | Grant | 50,000 | $0.00 | |
|
NeurogesX Inc NGSX
Common Stock
|
2012-01-31 | Grant | 20,000 | $1.01 | 20,200 |